Artificial Intelligence-Based Prediction of Progression from Gestational Diabetes to Type 2 Diabetes

Syeda Rizvi1, Mais Alkhateeb2, Farida Mohsen1

  • 1Hamad Bin Khalifa University, Doha, Qatar.

Women with a history of gestational diabetes mellitus (GDM) are at elevated risk of developing type 2 diabetes mellitus (T2DM) postpartum. This study explores the use of interpretable machine-learning models to examine associations between clinical, metabolic, lifestyle factors and postpartum diabetes status among women with history of GDM. A publicly available dataset of 1,496 women with prior GDM, comprising 29 medical, anthropometric, laboratory, and lifestyle variables, was analyzed. Eight classifiers were evaluated using 5-fold stratified cross-validation, including Logistic Regression (LogR), Decision Tree, Random Forest, Support Vector Machine, Naïve Bayes, K-Nearest Neighbor, XGBoost, and Multilayer Perceptron. Model performance was assessed using accuracy, recall, precision, F1-score, specificity, and AUC. LogR yielded the best accuracy (93.0%). Feature importance analyses identified HOMA-IR, C-peptide, uric acid, family history of diabetes, and AST as the strongest correlates of diabetes status. Given the lack of temporal information on feature measurement relative to diagnosis, results should be interpreted as associative rather than predictive. These findings demonstrate the utility of interpretable machine-learning approaches for exploratory postpartum diabetes risk stratification and underscore the need for future longitudinal validation.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...